Login / Signup

Benign prostatic hyperplasia - what do we know?

Conor M DevlinMatthew S SimmsNorman J Maitland
Published in: BJU international (2020)
BPH is an important disease, and as the pathogenesis is not fully understood it impacts the effectiveness of medical therapies. This impacts patients, with further research potentially highlighting novel therapeutic avenues.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • randomized controlled trial
  • healthcare
  • systematic review